Literature DB >> 20597129

Trends in incidence and survival of pediatric and adolescent patients with germ cell tumors in the United States, 1975 to 2006.

Jenny N Poynter1, James F Amatruda, Julie A Ross.   

Abstract

BACKGROUND: Pediatric germ cell tumors (GCTs) are rare and heterogeneous tumors with uncertain etiology. In the current study, data from the National Cancer Institute's Surveillance, Epidemiology and End Results (SEER) Program were used to evaluate trends in incidence and survival of GCTs in boys and girls ages ≤19 years. To the authors' knowledge, few studies to date have evaluated trends in pediatric GCTs. Results from these analyses may provide clues to the etiology of GCTs.
METHODS: Frequencies, incidence rates, and 5-year relative survival rates stratified by sex were evaluated overall and by demographic subgroups based on age (birth to 9 years and 10-19 years), race (white, black, and other), and ethnicity (non-Hispanic and Hispanic) as sample size permitted.
RESULTS: In whites, the incidence of GCTs was lower for females than males in the 10-year to 19-year age group (rate ratio [RR], 0.47; 95% confidence interval [95% CI], 0.42-0.53), whereas the rates were similar in the age group for birth to 9 years. In contrast, incidence rates were higher in black females than in black males in both age groups (RR, 2.01 [95%CI, 1.08-3.84] in those ages birth to 9 years; RR, 3.30 [95% CI, 2.13-5.28] in those ages 10-19 years). The incidence of ovarian GCT was significantly higher in Hispanic compared with non-Hispanic girls in the groups aged 10 to 19 years. Incidence rates increased during the study period in boys ages 10 to 19 years (annual percentage change [APC], 1.2; 95% CI, 0.4-2.1) and girls ages birth to 9 years (APC, 1.9; 95% CI, 0.3-2.5).
CONCLUSIONS: The incidence of pediatric GCTs in the United States appears to be increasing only in certain subgroups, suggesting that the etiology is not completely overlapping in all age groups. Differences in incidence patterns by race and ethnicity merit further investigation.
© 2010 American Cancer Society.

Entities:  

Mesh:

Year:  2010        PMID: 20597129      PMCID: PMC3931133          DOI: 10.1002/cncr.25454

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  70 in total

1.  In utero exposure to female hormones and germ cell tumors in children.

Authors:  Sadhna Shankar; Stella Davies; Roger Giller; Mark Krailo; Mary Davis; Kathleen Gardner; Hui Cai; Leslie Robison; Xiao-Ou Shu
Journal:  Cancer       Date:  2006-03-01       Impact factor: 6.860

2.  Incidence and survival rates for female malignant germ cell tumors.

Authors:  Harriet O Smith; Marianne Berwick; Claire F Verschraegen; Charles Wiggins; Letitia Lansing; Carolyn Y Muller; Clifford R Qualls
Journal:  Obstet Gynecol       Date:  2006-05       Impact factor: 7.661

3.  Risk factors for cancer of the testis in young men.

Authors:  B E Henderson; B Benton; J Jing; M C Yu; M C Pike
Journal:  Int J Cancer       Date:  1979-05-15       Impact factor: 7.396

4.  Risk of childhood germ cell tumors in association with parental smoking and drinking.

Authors:  Zhi Chen; Leslie Robison; Roger Giller; Mark Krailo; Mary Davis; Kathleen Gardner; Stella Davies; Xiao-Ou Shu
Journal:  Cancer       Date:  2005-03-01       Impact factor: 6.860

5.  Complete surgical excision is effective treatment for children with immature teratomas with or without malignant elements: A Pediatric Oncology Group/Children's Cancer Group Intergroup Study.

Authors:  N M Marina; B Cushing; R Giller; L Cohen; S J Lauer; A Ablin; R Weetman; J Cullen; P Rogers; C Vinocur; C Stolar; F Rescorla; E Hawkins; S Heifetz; P V Rao; M Krailo; R P Castleberry
Journal:  J Clin Oncol       Date:  1999-07       Impact factor: 44.544

6.  Cancer incidence among Hispanic children in the United States.

Authors:  James D Wilkinson; Alex Gonzalez; Brad Wohler-Torres; Lora E Fleming; Jill MacKinnon; Edward Trapido; Jaclyn Button; Steven Peace
Journal:  Rev Panam Salud Publica       Date:  2005-07

7.  Time trends in the incidence of testicular cancer in childhood and young adulthood.

Authors:  Hadriano M Lacerda; Olof Akre; Franco Merletti; Lorenzo Richiardi
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-06-16       Impact factor: 4.254

8.  The distribution and behavior of extragonadal primordial germ cells in Bax mutant mice suggest a novel origin for sacrococcygeal germ cell tumors.

Authors:  Christopher Runyan; Ying Gu; Amanda Shoemaker; Leendert Looijenga; Christopher Wylie
Journal:  Int J Dev Biol       Date:  2008       Impact factor: 2.203

9.  Influence of tumor site and histology on long-term survival in 193 children with extracranial germ cell tumors.

Authors:  A De Backer; G C Madern; R Pieters; P Haentjens; F G A J Hakvoort-Cammel; J W Oosterhuis; F W J Hazebroek
Journal:  Eur J Pediatr Surg       Date:  2008-02       Impact factor: 2.191

10.  Low doses of bisphenol A promote human seminoma cell proliferation by activating PKA and PKG via a membrane G-protein-coupled estrogen receptor.

Authors:  Adil Bouskine; Marielle Nebout; Françoise Brücker-Davis; Mohamed Benahmed; Patrick Fenichel
Journal:  Environ Health Perspect       Date:  2009-02-11       Impact factor: 9.031

View more
  34 in total

Review 1.  Zebrafish Germ Cell Tumors.

Authors:  Angelica Sanchez; James F Amatruda
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

Review 2.  Pediatric Gynecologic Cancers.

Authors:  Lauren Pommert; William Bradley
Journal:  Curr Oncol Rep       Date:  2017-07       Impact factor: 5.075

3.  The clinical impact of 18F-FDG PET/CT in extracranial pediatric germ cell tumors.

Authors:  Adam Hart; Reza Vali; Eman Marie; Furqan Shaikh; Amer Shammas
Journal:  Pediatr Radiol       Date:  2017-06-29

4.  Sex ratio among childhood cancers by single year of age.

Authors:  Lindsay A Williams; Michaela Richardson; Erin L Marcotte; Jenny N Poynter; Logan G Spector
Journal:  Pediatr Blood Cancer       Date:  2019-02-28       Impact factor: 3.167

5.  Increase in testicular germ cell tumor incidence among Hispanic adolescents and young adults in the United States.

Authors:  Franklin L Chien; Stephen M Schwartz; Rebecca H Johnson
Journal:  Cancer       Date:  2014-07-14       Impact factor: 6.860

6.  Revised risk classification for pediatric extracranial germ cell tumors based on 25 years of clinical trial data from the United Kingdom and United States.

Authors:  A Lindsay Frazier; Juliet P Hale; Carlos Rodriguez-Galindo; Ha Dang; Thomas Olson; Matthew J Murray; James F Amatruda; Claire Thornton; G Suren Arul; Deborah Billmire; Furqan Shaikh; Farzana Pashankar; Sara Stoneham; Mark Krailo; James C Nicholson
Journal:  J Clin Oncol       Date:  2014-12-01       Impact factor: 44.544

7.  Long-term outcomes and late effects for childhood and young adulthood intracranial germinomas.

Authors:  Sahaja Acharya; Todd DeWees; Eric T Shinohara; Stephanie M Perkins
Journal:  Neuro Oncol       Date:  2014-11-23       Impact factor: 12.300

8.  Global incidence comparisons and trends in ovarian germ cell tumors by geographic region in girls, adolescents and young women: 1988-2012.

Authors:  Aubrey K Hubbard; Jenny N Poynter
Journal:  Gynecol Oncol       Date:  2019-07-11       Impact factor: 5.482

9.  Incidence of intracranial germ cell tumors by race in the United States, 1992-2010.

Authors:  Jenny N Poynter; Rachel Fonstad; Jakub Tolar; Logan G Spector; Julie A Ross
Journal:  J Neurooncol       Date:  2014-08-03       Impact factor: 4.130

Review 10.  Pediatric and Adolescent Extracranial Germ Cell Tumors: The Road to Collaboration.

Authors:  Thomas A Olson; Matthew J Murray; Carlos Rodriguez-Galindo; James C Nicholson; Deborah F Billmire; Mark D Krailo; Ha M Dang; James F Amatruda; Claire M Thornton; G Suren Arul; Sara J Stoneham; Farzana Pashankar; Daniel Stark; Furqan Shaikh; David M Gershenson; Allan Covens; Jean Hurteau; Sally P Stenning; Darren R Feldman; Peter S Grimison; Robert A Huddart; Christopher Sweeney; Thomas Powles; Luiz Fernando Lopes; Simone dos Santos Agular; Girish Chinnaswamy; Sahar Khaleel; Sherif Abouelnaga; Juliet P Hale; A Lindsay Frazier
Journal:  J Clin Oncol       Date:  2015-08-24       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.